Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ORB-021 In Patients With Advanced Solid Tumors

NCT06607939 is registered in ClinicalTrials.gov with Orionis Biosciences Inc as lead sponsor.

NCT NCT06607939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06607939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ORB-021 In Patients With Advanced Solid Tumors
Lead sponsor
Orionis Biosciences Inc
Phase
Phase 1
Overall status
Recruiting
Start date
November 21, 2024
Completion date
May 31, 2027
Enrollment
36 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors cancer